Multivariable analysis of OS
| Covariate . | HR (95% CI) . | P value . |
|---|---|---|
| Time to first treatment | ||
| 15-60 d | Referent | |
| 0-14 d | 1.57 (1.20-2.06) | <.001 |
| Sex | ||
| Female | Referent | |
| Male | 1.60 (1.15-2.23) | .005 |
| Ann Arbor stage | ||
| 1-3 | Referent | |
| 4 | 1.02 (0.56-1.87) | .94 |
| BM involvement | ||
| No | Referent | |
| Yes | 1.25 (0.71-2.21) | .44 |
| B symptoms | ||
| No | Referent | |
| Yes | 1.13 (0.85-1.51) | .38 |
| MIPI | ||
| <5.7 | Referent | |
| ≥5.7 <6.2 | 1.28 (0.92-1.79) | .14 |
| ≥6.2 | 2.50 (1.81-3.46) | <.001 |
| Intensive induction therapy | ||
| No | Referent | |
| Yes | 0.77 (0.59-1.01) | .06 |
| Covariate . | HR (95% CI) . | P value . |
|---|---|---|
| Time to first treatment | ||
| 15-60 d | Referent | |
| 0-14 d | 1.57 (1.20-2.06) | <.001 |
| Sex | ||
| Female | Referent | |
| Male | 1.60 (1.15-2.23) | .005 |
| Ann Arbor stage | ||
| 1-3 | Referent | |
| 4 | 1.02 (0.56-1.87) | .94 |
| BM involvement | ||
| No | Referent | |
| Yes | 1.25 (0.71-2.21) | .44 |
| B symptoms | ||
| No | Referent | |
| Yes | 1.13 (0.85-1.51) | .38 |
| MIPI | ||
| <5.7 | Referent | |
| ≥5.7 <6.2 | 1.28 (0.92-1.79) | .14 |
| ≥6.2 | 2.50 (1.81-3.46) | <.001 |
| Intensive induction therapy | ||
| No | Referent | |
| Yes | 0.77 (0.59-1.01) | .06 |
Boldface value signifies statistically significant value.